Price $13.81 |
Market Cap
1.1B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.12
|
P/S
4.05
|
Dividend %
-
|
|
P/CF
254.1
|
P/FCF
56.2
|
Op. Cash Flow
34K
|
FCF
0.2
|
|
Op. Margin
1.90%
|
Net Margin
-4.00%
|
ROE
-6.10%
|
ROI
0.70%
|
|
ROA
-3.00%
|
EPS Growth
64.50%
|
Current Ratio
2.4
|
Debt/Equity
56.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Health Industries Holdin (CHHE) | $0.80 | - | - | 60.3M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.69 | - | - | 87.7M | Strong Buy |
| Reliv International, Inc (RELV) | $4.87 | - | - | 8.9M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.53 | - | 3.50% | 24.52B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
